Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Neurology

Do Thyroid Antibodies Cause Brain Inflammation in SREAT?

At a Glance

In SREAT, anti-TPO and anti-thyroglobulin antibodies are evidence of thyroid autoimmunity, but they are not proven to directly inflame or damage the brain. Antibody levels do not reliably measure symptom severity or recovery, so clinicians focus on symptoms and other tests.

It is understandable to fear that a high antibody number means ongoing damage to your brain, but current evidence does not support this. Anti-thyroid peroxidase (anti-TPO) and anti-thyroglobulin (anti-TG) antibodies are associated with autoimmune thyroid disease and are often used as part of the evaluation for Steroid-Responsive Encephalopathy Associated with Autoimmune Thyroiditis (SREAT, also known as Hashimoto’s encephalopathy). However, they are not proven to directly attack the brain [1][2]. Instead, the antibodies are supportive evidence of thyroid autoimmunity, but their presence alone does not establish SREAT or prove that they are the cause of your symptoms [1][2].

The Role of Thyroid Antibodies in Diagnosis

SREAT is a clinical diagnosis of exclusion, meaning doctors must first rule out other more common or treatable causes of encephalopathy (a general term for brain dysfunction), such as infections, metabolic issues, medication effects, or other types of autoimmune encephalitis [2]. While high thyroid antibodies are a clue that helps point toward SREAT, many people have these antibodies without ever developing neurological issues [1].

Although studies have sometimes detected low levels of thyroid antibodies in the cerebrospinal fluid (the fluid surrounding the brain and spinal cord) of SREAT patients, their presence there does not prove they are causing neuronal injury [3]. Some studies have found very low concentrations in the spinal fluid and no evidence that they actively cross the blood-brain barrier to cause damage [4].

Because these antibodies are simply markers of an autoimmune state, their levels in your blood do not reliably reflect the severity of your neurological symptoms [5][6]. A person can have very high antibody levels with mild symptoms, or lower levels with severe symptoms. Additionally, the level of anti-TPO or anti-TG does not reliably predict how well you will respond to corticosteroid treatments [7]. Therefore, doctors do not use antibody levels alone to diagnose SREAT or to monitor your recovery progress [5][7]. Monitoring your condition usually focuses on your clinical symptoms, cognitive function, and thyroid hormone status, rather than chasing the antibody number.

How Might SREAT Cause Neurologic Symptoms?

If the thyroid antibodies are not directly causing the damage, what is? The exact mechanism remains uncertain, and objective evidence of brain inflammation is not always present in SREAT. Researchers are exploring several hypotheses for how the condition might develop:

  • T-Cell Driven Neuroinflammation: Some evidence suggests that certain immune cells, specifically T-cells, might drive inflammation in the nervous system [8][9].
  • Molecular Mimicry: This theory proposes that the immune system might confuse specific proteins in the brain with thyroid proteins, leading to an unintended immune response [10].
  • Blood-Brain Barrier Dysfunction: There is some indirect evidence that the protective barrier between the blood and the brain may become temporarily compromised, allowing inflammatory cells or proteins to enter [11].

Currently, these remain research theories rather than established facts [10][8][9]. The key takeaway is that a high antibody level is evidence of thyroid autoimmunity, not a direct measure of brain damage.

When to Seek Urgent Care

Because SREAT symptoms can fluctuate and overlap with other serious conditions, it is important not to attribute every new symptom to your antibodies. Seek urgent or emergency medical assessment if you experience sudden or severe confusion, a seizure, loss of consciousness, new weakness or speech difficulty, or rapidly worsening balance. These presentations require immediate evaluation to rule out other emergencies, such as infections or strokes, and should not be self-managed.

Common questions in this guide

Do thyroid antibodies directly attack the brain in SREAT?
Current evidence does not prove that anti-TPO or anti-thyroglobulin antibodies directly attack or damage brain cells. These antibodies are mainly markers of autoimmune thyroid disease and can support a SREAT evaluation, but their presence does not establish the cause of neurological symptoms.
Does a higher thyroid antibody level mean that SREAT symptoms will be worse?
No. Blood levels of anti-TPO and anti-thyroglobulin antibodies do not reliably match the severity of neurological symptoms or predict response to corticosteroid treatment. Clinicians generally follow symptoms, cognitive function, and thyroid hormone status instead of using the antibody number alone.
Can positive thyroid antibodies by themselves diagnose SREAT?
No. SREAT is a diagnosis of exclusion, so clinicians must first evaluate other possible causes of brain dysfunction, including infection, metabolic problems, medication effects, and other autoimmune encephalitides. Many people have thyroid antibodies without developing neurological problems.
What might cause neurological symptoms in SREAT if the antibodies are not directly damaging the brain?
The exact mechanism is uncertain. Researchers are studying possible roles for immune cells, mistaken immune targeting of brain proteins, and temporary changes in the blood-brain barrier, but these explanations remain theories rather than established facts.
When should I seek urgent care for possible SREAT symptoms?
Seek urgent or emergency medical assessment for sudden or severe confusion, a seizure, loss of consciousness, new weakness or speech difficulty, or rapidly worsening balance. These symptoms can have other serious causes, such as infection or stroke, and should not be attributed to thyroid antibodies without evaluation.

Get notified when new evidence is published on Steroid-responsive encephalopathy associated with autoimmune thyroiditis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    Hashimoto's Encephalopathy: Case Series and Literature Review.

    Chaudhuri J, Mukherjee A, Chakravarty A

    Current neurology and neuroscience reports 2023; (23(4)):167-175 doi:10.1007/s11910-023-01255-5.

    PMID: 36853554
  2. 2

    Brain dysfunction and thyroid antibodies: autoimmune diagnosis and misdiagnosis.

    Valencia-Sanchez C, Pittock SJ, Mead-Harvey C, et al.

    Brain communications 2021; (3(2)):fcaa233 doi:10.1093/braincomms/fcaa233.

    PMID: 34061124
  3. 3

    Steroid-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): Characteristics, treatment and outcome in 251 cases from the literature.

    Laurent C, Capron J, Quillerou B, et al.

    Autoimmunity reviews 2016; (15(12)):1129-1133 doi:10.1016/j.autrev.2016.09.008.

    PMID: 27639840
  4. 4

    Thyroid Autoantibodies in the Cerebrospinal Fluid of Subjects with and without Thyroid Disease: Implications for Hashimoto's Encephalopathy.

    Ilias I, Karagiorga V, Paraskevas G, et al.

    Journal of thyroid research 2015; (2015()):819072 doi:10.1155/2015/819072.

    PMID: 26798549
  5. 5

    Encephalopathy Associated with Autoimmune Thyroid Disease: A Potentially Reversible Condition.

    Correia I, Marques IB, Ferreira R, Sousa L

    Case reports in medicine 2016; (2016()):9183979 doi:10.1155/2016/9183979.

    PMID: 27127515
  6. 6

    Hashimoto encephalopathy in pediatric patients: Homogeneity in clinical presentation and heterogeneity in antibody titers.

    Lee J, Yu HJ, Lee J

    Brain & development 2018; (40(1)):42-48 doi:10.1016/j.braindev.2017.07.008.

    PMID: 28784301
  7. 7

    Hashimoto encephalopathy in the 21st century.

    Mattozzi S, Sabater L, Escudero D, et al.

    Neurology 2020; (94(2)):e217-e224 doi:10.1212/WNL.0000000000008785.

    PMID: 31882532
  8. 8

    Patients with a relapsing course of steroid-responsive encephalopathy associated with autoimmune thyroiditis exhibit persistent intrathecal CD4+ T-cell activation.

    Pfeuffer S, Ruck T, Rolfes L, et al.

    European journal of neurology 2021; (28(4)):1284-1291 doi:10.1111/ene.14657.

    PMID: 33230897
  9. 9

    HMGB1 dysregulation: a neuroimmune bridge to cognitive impairment in autoimmune thyroiditis.

    Wang J, Chu G, Ding L, et al.

    Frontiers in immunology 2026; (17()):1764288 doi:10.3389/fimmu.2026.1764288.

    PMID: 41782877
  10. 10

    Amino acid sequence homology between thyroid autoantigens and central nervous system proteins: Implications for the steroid-responsive encephalopathy associated with autoimmune thyroiditis.

    Benvenga S, Antonelli A, Fallahi P, et al.

    Journal of clinical & translational endocrinology 2021; (26()):100274 doi:10.1016/j.jcte.2021.100274.

    PMID: 34849350
  11. 11

    An observational study on the association of anti-thyroid autoantibodies with clinical, EEG, MRI, FDG-PET, cerebrospinal fluid and anti-neuronal antibody findings in 530 patients with schizophreniform and affective disorders.

    Endres D, Runge K, Meixensberger S, et al.

    Psychoneuroendocrinology 2021; (131()):105320 doi:10.1016/j.psyneuen.2021.105320.

    PMID: 34171794

This page is for informational purposes only and does not constitute medical advice. Your neurologist and other clinicians should interpret thyroid antibody results and neurological symptoms in the context of your individual evaluation.